GH Research PLC (GHRS) vs Novavax, Inc. (NVAX)
GH Research PLC and Novavax, Inc. are both Biotechnology companies. GH Research PLC and Novavax, Inc. are of similar size ($1.8B and $1.7B). GH Research PLC has the higher net margin (0.00% vs −59.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, GH Research PLC leads on 6 and Novavax, Inc. on 6.
Valuation
Profitability
| Metric | GHRS | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 78.60% | 65.16% |
| Operating margin | 0.00% | (56.58%) | 0.00% |
| Net margin | 0.00% | (59.87%) | 0.00% |
| Free cash flow margin | 0.00% | (10.20%) | 0.00% |
| Return on equity | (18.79%) | 323.66% | (57.72%) |
| Return on assets | (18.16%) | (21.62%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack